Login / Signup
Latest FDA-approved drug nirsevimab-alip (Beyfortus): A gamechanger for treatment of respiratory syncytial virus.
Muhammad Talha
Mohammad Haris Ali
Published in:
Journal of medical virology (2023)
Keyphrases
</>
respiratory syncytial virus
emergency department
drug administration
combination therapy